Physician profile
John Kimball
NPI 1083382634
$515.32
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.13 · 2022: $404 · 2023: $18.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.61.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $133.23 | 2021-2022 | |
| Novo Nordisk INC | $93.66 | 2021-2023 | Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $38.24 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $36.94 | 2022 | |
| Pfizer INC. | $33.78 | 2022 | |
| Abbvie INC. | $32.84 | 2021-2022 | |
| Cardiovascular Systems INC. | $26.81 | 2022 | |
| Hologic Sales and Service, LLC | $20.01 | 2022 | |
| Eisai INC. | $18.99 | 2022 | |
| Seqirus USA INC | $18.75 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $18.04 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.17 | 2022 | |
| Philips North America LLC | $15.04 | 2021 | |
| Merck Sharp & Dohme LLC | $13.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kimball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.